Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Patients willing to participate and sign consent in the clinical trial. • Patients in the age group of 18-65 yrs. • Patients with Intermittent, mild-persistent & moderate-persistent asthma and are not on regular medication for Asthma. • Patients having FEV1 > 60% of predicted value • Patients of Rhinitis with spirometric evidence of reversible airflow obstruction. • Patients who have not received any AYUSH intervention in last 15 days for related symptoms
Exclusion criteria
Exclusion criteria: • Patients having severe persistent (FEV1 • Diagnosed cases of tuberculosis, pneumonia, COPD and other acute and chronic pulmonary disorders • K/c/o malignancies of the respiratory and other system. • Patients who have consumed AYUSH intervention for related complaints in last 15 days. • Patients on regular anti allergic medications, on regular inhaled, intranasal or oral steroids. • Patients on immunotherapy for allergy. • Patients with Haemoglobin less than 9 mg/dl. • Patients having concomitant systemic illness like uncontrolled Hypertension, Poorly controlled Diabetes Mellitus, Renal failure, Malignancy, Acute or Chronic liver disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Forced Expiratory Volume in first second (FEV1) from baseline values.Timepoint: 56 days | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Improvement in Peak expiratory flow rate (PEFR). â?¢ Changes in IgE & Absolute Eosinophil count â?¢ Degree of improvement in asthma related symptoms on the basis of Asthma control questionnaire (ACQ) â?¢ Degree of Improvement in Total Nasal Symptom Score (TNSS) Timepoint: 56 days | — |
Countries
India
Contacts
National Institute of Ayurveda